More articles from Commentary

You have access
Vulnerable Populations: Health care practitioners’ responsibility to address intimate partner violence related to the COVID-19 pandemic
Nori L. Bradley, Ashley M. DiPasquale, Kaitlyn Dillabough and Prism S. Schneider

CMAJ June 01, 2020 192 (22) E609-E610; DOI: https://doi.org/10.1503/cmaj.200634
You have access
Health Services: Confronting the COVID-19 surgery crisis: time for transformational change
David R. Urbach and Danielle Martin

CMAJ May 25, 2020 192 (21) E585-E586; DOI: https://doi.org/10.1503/cmaj.200791
You have access
Renin–angiotensin–aldosterone system inhibitors and COVID-19
Kieran L. Quinn, Michael Fralick, Jonathan S. Zipursky and Nathan M. Stall

CMAJ May 19, 2020 192 (20) E553-E554; DOI: https://doi.org/10.1503/cmaj.200619
You have access
Health Services: Redesign of a rural emergency department to prepare for the COVID-19 pandemic
Christopher Patey, Shabnam Asghari, Paul Norman and Oliver Hurley

CMAJ May 11, 2020 192 (19) E518-E520; DOI: https://doi.org/10.1503/cmaj.200509
You have access
What happens when laboratory reference ranges change?
Duncan J. Topliss

CMAJ May 04, 2020 192 (18) E481-E482; DOI: https://doi.org/10.1503/cmaj.200511
You have access
Mental Health: Mitigating the psychological effects of COVID-19 on health care workers
Peter E. Wu, Rima Styra and Wayne L. Gold

CMAJ April 27, 2020 192 (17) E459-E460; DOI: https://doi.org/10.1503/cmaj.200519
You have access
Global Initiative for Asthma report: How will new recommendations affect practice in Canada?
Marie-France Beauchesne and Catherine Lemiere

CMAJ April 27, 2020 192 (17) E456-E458; DOI: https://doi.org/10.1503/cmaj.191445
You have access
Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic
Matthew P. Cheng, Todd C. Lee, Darrell H.S. Tan and Srinivas Murthy

CMAJ April 14, 2020 192 (15) E405-E407; DOI: https://doi.org/10.1503/cmaj.200438
You have access
Health Services: Optimizing provision of extracorporeal life support during the COVID-19 pandemic: practical considerations for Canadian jurisdictions
Ken Kuljit S. Parhar, Laurance Lequier, Jaime Blackwood, Danny J. Zuege and Gurmeet Singh

CMAJ April 06, 2020 192 (14) E372-E374; DOI: https://doi.org/10.1503/cmaj.200448
You have access
Should sodium-glucose cotransporter-2 inhibitors be first-line treatment for patients with type 2 diabetes?
Carl van Walraven

CMAJ April 06, 2020 192 (14) E375-E376; DOI: https://doi.org/10.1503/cmaj.200426

Main menu

User menu

Search

More articles from Commentary

Pages

Content

Information for

About